Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

A propensity-score matched cohort study found a significantly reduced risk of recurrence of bladder cancer in patients who ...

But with this increase in digital consumption comes the inevitable eye strain caused by the blue light emitted from our devices. The British Medical Journal describes this syndrome as “encompass ...

OSLO, Norway, March 14, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study "Oncologic Outcomes of Blue Light Cystoscopy in an Equal ...

The Blue Light Card, which offers discounts to emergency workers, has since expanded to include other professions, including education. The card costs £4.99 for two years of access to thousands ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announced the appointment of Jane Healy as Vice President and General Manager ...

Blue Light Cystoscopy Delays Time to Recurrence in Non-Muscle Invasive Bladder Cancer Patients Treated in a Real-World Setting Siamak Daneshmand, MD Siamak Daneshmand demonstrated that blue light ...

We know the importance of using Blue Light Cystoscopy in the precision diagnostic pathway for bladder cancer, where accurate staging and resection helps determine the optimal treatment decisions ...

Williams, MD, MBA, MS, FACS, FACHE. The use of blue light cystoscopy (BLC) was associated with a reduced risk of recurrence among patients with non–muscle invasive bladder cancer (NMIBC), according to ...